Inspection Readiness (Quality)

Inspection readiness from a quality perspective means your quality systems, SOPs, training records, deviations, and CAPAs can withstand FDA scrutiny without last-minute scrambling. Investigators look at written procedures and how people actually follow them on the floor and in the systems of record. Viltis helps quality and operations teams prepare evidence packs, walk-through narratives, and response discipline so inspection days stay controlled and factual.

Readiness work usually starts with a focused review of the quality management system: document control, change control, complaint handling, batch or study records, and CAPA effectiveness. Gaps often show up as open deviations past due dates, incomplete training matrices, or SOP revisions that never reached the floor. Closing those gaps before an FDA visit reduces observation risk and keeps subject-matter experts from improvising under pressure when files are requested.

Mock inspections are useful when they mirror real investigator behavior. That means timed document retrieval, interview practice for front-line staff, and clear rules for who speaks, who takes notes, and how commitments get recorded. Our consultants run readiness assessments that surface weak answers early, then help teams rewrite talking points so they stay accurate and within the scope of the question asked without volunteering unrelated problems.

During an active inspection, support may include war-room coordination, document staging, and real-time review of draft responses before they leave the room. Viltis provides consulting and embedded resources; we do not issue certificates or replace your quality unit's accountability for release and oversight decisions. Preparation should leave your team able to explain processes calmly with the records to back them up.

Quality-focused inspection readiness typically includes

• Quality system and SOP gap reviews against FDA inspection themes
• Mock inspections with timed document retrieval and interview practice
• Deviation, CAPA, and training record readiness checks
• Inspection room roles, logistics, and communication protocols
• Evidence pack assembly for high-risk processes and recent changes
• On-site or remote support during active FDA inspections

If an inspection window is approaching or a prior Form 483 left open questions, structured readiness work is often the fastest way to reduce surprise findings and protect product or study timelines. Reach out to discuss a focused assessment tailored to your site, product line, or clinical program.